These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 21739365)

  • 1. Role of various proteases in cardiac remodeling and progression of heart failure.
    Müller AL; Dhalla NS
    Heart Fail Rev; 2012 May; 17(3):395-409. PubMed ID: 21739365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of protease activation in cardiac dysfunction and development of genetic cardiomyopathy in hamsters.
    Müller AL; Freed D; Hryshko L; Dhalla NS
    Can J Physiol Pharmacol; 2012 Aug; 90(8):995-1004. PubMed ID: 22784245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.
    Dhalla NS; Rangi S; Babick AP; Zieroth S; Elimban V
    Heart Fail Rev; 2012 Sep; 17(4-5):671-81. PubMed ID: 21850540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
    Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial proteases and cardiac remodeling.
    Riaz S; Zeidan A; Mraiche F
    J Cell Physiol; 2017 Dec; 232(12):3244-3250. PubMed ID: 28255990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
    Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
    Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts.
    Jana S; Zhang H; Lopaschuk GD; Freed DH; Sergi C; Kantor PF; Oudit GY; Kassiri Z
    J Am Heart Assoc; 2018 Oct; 7(19):e010427. PubMed ID: 30371322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
    Frangogiannis NG
    Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies.
    Takano H; Hasegawa H; Nagai T; Komuro I
    Intern Med; 2003 Jun; 42(6):465-9. PubMed ID: 12857042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice.
    Su H; Li J; Menon S; Liu J; Kumarapeli AR; Wei N; Wang X
    Circ Res; 2011 Jan; 108(1):40-50. PubMed ID: 21051661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system.
    Pauschinger M; Chandrasekharan K; Schultheiss HP
    Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
    Babick AP; Dhalla NS
    Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future scope and challenges for congestive heart failure: moving toward development of pharmacotherapy.
    Dhalla NS; Bhullar SK; Shah AK
    Can J Physiol Pharmacol; 2022 Sep; 100(9):834-847. PubMed ID: 35704943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.
    Schirone L; Forte M; Palmerio S; Yee D; Nocella C; Angelini F; Pagano F; Schiavon S; Bordin A; Carrizzo A; Vecchione C; Valenti V; Chimenti I; De Falco E; Sciarretta S; Frati G
    Oxid Med Cell Longev; 2017; 2017():3920195. PubMed ID: 28751931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruptions and detours in the myocardial matrix highway and heart failure.
    Deschamps AM; Spinale FG
    Curr Heart Fail Rep; 2005 Mar; 2(1):10-7. PubMed ID: 16036046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury.
    Müller AL; Hryshko LV; Dhalla NS
    Int J Cardiol; 2013 Mar; 164(1):39-47. PubMed ID: 22357424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy.
    Sivakumar P; Gupta S; Sarkar S; Sen S
    Mol Cell Biochem; 2008 Jan; 307(1-2):159-67. PubMed ID: 17849172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.